Tom Wood

OGL Construction & OPM Group unite to cycle 300 miles from Pisa to Rome for Big Bob’s Myeloma UK Fundraiser

Fundraising for Myeloma UK
raised of £7,500 target
by 71 supporters
Donations cannot currently be made to this page
Team OGL Pisa - Rome , 20 September 2023
Myeloma UK

Verified by JustGiving

RCN SC026116
We provide support and fund vital research to make myeloma history


Tom met Bob Munro 20 years ago when Bob’s sons, Ross & Joe, became his school friends. In 2012, Bob was diagnosed with the incurable blood cancer Myeloma and despite the grim prognosis, is still with us today, thanks to the remarkable number of new drugs that Myeloma UK, and others, have helped develop, trial and make available to patients like Bob.

In 2016, Tom and his family were part of Bob’s team of 45 family and friends who cycled in the inaugural London - Paris event which was founded by Bob and has since raised over £1.5 million for Myeloma UK.

This September Tom and his partner Charlotte have decided to join forces and create ‘Team OGL & OPM’ to join ‘Team Bob’ and cycle 4 days over the challenging 300 mile route from Pisa, through the hills of Tuscany to Rome.

Please sponsor us to help keep patients like Bob alive and to help find the cure.

All of the cyclists pay for all their own costs/trips, so 100% of your donation goes directly to Myeloma UK.

Thank you from Tom, Charlotte, Jasper, Bob & Family and all Myeloma Patients.

Bob’s Story, in his own words:

By early 2022 I had survived a remarkable 10 years with the rare and incurable blood cancer Myeloma, and amongst other life events, I had welcomed the granddaughter I thought I would never see, into our family. But, I had used and exhausted all the available licensed drugs that had kept me alive, literally, against the odds, so my bio markers were rising and my brittle bones, ribs in particular, were fracturing with the slightest cough or movement (10 fractures in 2 years). In February 2023 I managed to join a trial for a new class of drug to tackle Myeloma and after a rollercoaster year of multiple debilitating side-effects, the worst of which left me unable to walk, I emerged with my first ever complete remission after 11 years of continuous treatment. A minor miracle? Not a cure, but I'll definitely take it.

What has enabled me, and other patients, to survive longer than the stats in 2012 suggested we would, has been the accelerated development of an incredible number of new drugs (more than for any other cancer). The Pharma companies take enormous credit for this but so too do the powerful patient advocacy groups such as Myeloma UK (the only dedicated Myeloma charity in the UK), who fund research, trials (like mine) and ensure the lengthy process of 'bench to bedside' for new drugs is foreshortened as much as possible, by making sure the patient voice is heard.

That is why I am so passionate about fundraising for Myeloma UK. They are literally helping to save the lives of patients like me.

This year 40 of my family and friends are cycling a challenging 300 miles from Pisa, through the hills of Tuscany to Rome.

Please sponsor us to help save the lives of Myeloma patients and help us find a cure.

Thanks for taking the time to visit my JustGiving page.

Donating through JustGiving is simple, fast and totally secure. Your details are safe with JustGiving - they'll never sell them on or send unwanted emails. Once you donate, they'll send your money directly to the charity. So it's the most efficient way to donate - saving time and cutting costs for the charity.

About the charity

Myeloma UK

Verified by JustGiving

RCN SC026116
Myeloma UK is the only organisation in the UK dealing exclusively with myeloma. We provide information and support to patients and their families and help myeloma patients live longer, with a better quality of life by accelerating the discovery, development of and access to new treatments.

Donation summary

Total raised
+ £772.78 Gift Aid
Online donations
Offline donations

* Charities pay a small fee for our service. Find out how much it is and what we do for it.